The safety of medications to treat Ulcerative Colitis (UC) and Crohn's Disease (CD) during pregnancy and lactation is very important to women who have an infant. Some of these UC and CD medications may be transferred in utero or through breast milk from nursing inflammatory bowel disease (IBD), so doctors are conducting a research study to find out more.
Right now, women ages 18 and older who are taking vedolizumab for Ulcerative Colitis or Crohn's Disease and breastfeeding a child can enroll in a clinical research study. If you qualify, you'll participate for up to about 3 months, and will make up to 7 visits to the study clinic during that time. Some visits may be conducted in your home by a study staff member for your convenience.
The research study is testing the concentration of vedolizumab in breast milk. No samples will be collected from the breastfed infants in this study.
The study team will check other requirements to be sure that you're eligible for this study.See if you may qualify.
If you have questions or comments, please call us at
1-877-212-7572 or e-mail Vedo4001@ppdi.com.